Lisata Therapeutics Inc Share Price

NASDAQ: LSTA

Small Cap

$2.29

+0.17

(+8.25%)

as on September 17, 2025 at 1:25 am IST

$₹

Lisata Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:25 am IST

Day's Low
$2.17
Day's Price Range
$2.29
$2.29
5.24%
Downside
52 Week's Low
52 Week's High
$1.87
52-Week Price Range
$4.2
$2.29
18.34%
Downside
83.41%
Upside

Lisata Therapeutics Inc share price movements today

Previous Close: $2.12
Open: $2.17
Volume: 145.8K
Day's Low - High: $2.17 - $2.29
52 Week Low - High: $1.87 - $4.2

Lisata Therapeutics Inc Historical Returns

1 Month Return: -16.21 %
3 Month Return: -15.54 %
1 Year Return: -27.15 %
3 Year Return: -57.6 %
5 Year Return: 0 %

Lisata Therapeutics Inc Stock Fundamentals & Key Indicators

Check Lisata Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.2M

EPS (TTM)

-2.2267

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-20.8M

Revenue (TTM)

1.1M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Lisata Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lisata Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lisata Therapeutics Inc	BUY	$19.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Lisata Therapeutics Inc Stock including INR - Dollar returns

The Lisata Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lisata Therapeutics Inc investment value today

Current value as on today

₹83,562

Returns

₹16,438

(-16.44%)

Returns from Lisata Therapeutics Inc Stock

₹21,306 (-21.31%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Lisata Therapeutics Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Lisata Therapeutics Inc. Average target price of $20.67

Lisata Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Lisata Therapeutics Inc.

What analysts predicted

88.92%UPSIDE

Target Price

$20.67

Current Price

$2.29

Analyzed by

9 Analysts

Target

$20.67

Lisata Therapeutics Inc target price $20.67, a slight upside of 88.92% compared to current price of $2.29. According to 9 analysts rating.

Lisata Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Lisata Therapeutics Inc Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:20% versus previous 30 day period

Lisata Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	1	-	0
Gross Profit	0	0	0	0	0	0	0	1	0	0
Operating Income	-6	-6	-5	-6	-6	-5	-5	-4	-5	-4
EBITDA	-6	-6	-5	-5	-6	-5	-5	-4	-5	-4
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-6	-5	-5	-6	-5	-4	-4	-5	-4
Income Tax Expense	-1	-2	0	0	0	-	-	-19	0	-
Net Income	-6	-4	-5	-5	-5	-5	-4	-4	-4	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-461.00%	0.00%	-6655.71%

Lisata Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	22	35	-	-	-	-	121	-	1
Gross Profit	2	4	0	0	0	0	63	0	1
Operating Income	-51	-31	-16	-20	-19	-29	-57	-25	-22
EBITDA	-93	-29	-16	-20	-19	-28	-56	-25	-22
Interest Expense	2	1	0	-	0	0	1	-	-
Depreciation	-	-	0	0	0	0	0	0	0
Income Before Tax	-98	-31	-16	-19	-19	-28	-56	-23	-20
Income Tax Expense	-17	0	0	0	-10	-1	-2	-2	0
Net Income	-80	-32	-16	-20	-8	-27	-54	-20	-19
Net Profit Margin	-359.69%	-92.55%	0.00%	0.00%	0.00%	0.00%	-44.68%	0.00%	-1998.50%

Lisata Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-5	-5	-5	-5	-4	-4	-4	-4
Operating Cash Flow	-4	-3	-4	-7	-5	-2	-4	-5	-3
Investing Cash Flow	0	12	-5	6	11	-6	1	9	0
Financing Cash Flow	0	0	0	0	0	-	0	0	0
Change in Cash	-4	8	-9	0	6	-8	-3	4	-3

Lisata Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-33	-16	-16	-19	-8	-27	-54	-20	-19
Operating Cash Flow	-23	-20	-19	-18	-8	-22	-21	-20	-19
Investing Cash Flow	-2	41	-4	21	-7	-54	28	10	13
Financing Cash Flow	20	0	0	1	18	85	0	0	0
Change in Cash	-5	19	-23	3	2	8	7	-9	-6

Global Institutional Holdings in Lisata Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	2.96%
BML Capital Management LLC	2.52%
Renaissance Technologies Corp	1.19%
Geode Capital Management, LLC	0.7%
BlackRock Inc	0.64%

See all

Insights on Lisata Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 97.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 174.1%
NEGATIVE IMPACT
Price Dip
In the last 1 month, LSTA stock has moved down by -16.2%

About Lisata Therapeutics Inc

caladrius biosciences, inc., a clinical-stage biopharmaceutical company, develops cellular therapeutic product candidates to address diseases and conditions caused by ischemia. its product candidates include developmental treatments for cardiovascular diseases, such as clbs12 for the treatment of critical limb ischemia; clbs16, which is in phase ii clinical trial for the treatment of coronary microvascular dysfunction; clbs14, a regenerative medicine advanced therapy for treating no-option refractory disabling angina. the company was formerly known as neostem, inc. and changed its name to caladrius biosciences, inc. in june 2015. caladrius biosciences, inc. was founded in 1980 and is headquartered in basking ridge, new jersey.

Organisation	Lisata Therapeutics Inc
Headquarters	110 Allen Road, Basking Ridge, NJ, United States, 07920
CEO	Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.
E-voting on shares	Click here to vote

Key Management of Lisata Therapeutics Inc

Name	Title
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.	President, CEO & Director
Mr. James Nisco	Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer
Dr. Kristen K. Buck M.D.	Executive VP of R&D and Chief Medical Officer
Mr. Tariq Imam	Senior VP of Business Development & Operations and General Counsel
Mr. Gregory S. Berkin	Chief Information & Data Protection Officer
Mr. John D. Menditto	Vice President of Investor Relations & Corporate Communications
Dr. William K. Sietsema Ph.D.	Vice President of Global Regulatory Affairs

FAQs

What is Lisata Therapeutics Inc share price today?

Lisata Therapeutics Inc share price today is $2.29 as on September 17, 2025 at 1:25 am IST at the close of the market. Lisata Therapeutics Inc share today touched a day high of $2.29 and a low of $2.17.

What is the 52 week high and 52 week low for Lisata Therapeutics Inc share?

Lisata Therapeutics Inc share touched a 52 week high of $4.2 on January 6, 2025 and a 52 week low of $1.87 on April 7, 2025. Lisata Therapeutics Inc stock price today i.e. September 17, 2025 at 1:25 am IST is closed at $2.29,which is 45.48% down from its 52 week high and 22.46% up from its 52 week low.

What is Lisata Therapeutics Inc's market capitalisation today?

Lisata Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:25 am IST.

How to invest in Lisata Therapeutics Inc Stock (LSTA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lisata Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lisata Therapeutics Inc Shares that will get you 0.6550 shares as per Lisata Therapeutics Inc share price of $2.29 per share as on September 17, 2025 at 1:25 am IST.

What is the minimum amount required to buy Lisata Therapeutics Inc Stock (LSTA) from India?

Indian investors can start investing in Lisata Therapeutics Inc (LSTA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 2:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Lisata Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 2:43 am IST). Based on Lisata Therapeutics Inc share’s latest price of $2.29 as on September 17, 2025 at 1:25 am IST, you will get 4.3668 shares of Lisata Therapeutics Inc. Learn more about fractional shares .